Vaccine therapy for treatment of endometrial and ovarian cancer Grant US-11338025-B2 United States of America 24 May 2022
Diagnostic evaluation of antibody responses to commonly recognized prostate cancer-associat… Grant US-11143656-B2 United States of America 12 Oct 2021
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof Grant US-10597450-B2 United States of America 24 Mar 2020
Diagnostic evaluation of antibody responses to commonly recognized prostate cancer-associat… Grant US-10191056-B2 United States of America 29 Jan 2019
Peptide vaccine therapy for treatment of FRα-expressing tumors Grant US-9993538-B2 United States of America 12 Jun 2018
Anti-kidney associated antigen 1 (KAAG1) antibodies Grant US-9855291-B2 United States of America 02 Jan 2018
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof Grant US-9828426-B2 United States of America 28 Nov 2017
Induction of tumor immunity by variants of folate binding protein Grant US-9562070-B2 United States of America 07 Feb 2017
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof Grant US-9393302-B2 United States of America 19 Jul 2016
Antibodies against kidney associated antigen 1 and antigen binding fragments thereof Grant US-8937163-B2 United States of America 20 Jan 2015
Induction of tumor immunity by variants of folate binding protein Grant US-8815256-B2 United States of America 26 Aug 2014
ZAP-70 expression as a marker for chronic lymphocytic leukemia / small lymphocytic… Grant US-8748114-B2 United States of America 10 Jun 2014
Methods and compositions for categorizing patients Application US-8722350-B2 United States of America 13 May 2014
Process for the production of immunogenic compositions Grant US-8597656-B2 United States of America 03 Dec 2013
Antibodies that specifically block the biological activity of kidney associated antigen 1 … Grant US-8580257-B2 United States of America 12 Nov 2013
Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic… Grant US-8524652-B2 United States of America 03 Sep 2013
MAGEA3 BINDING ANTIBODIES Application WO-2012163771-A1 World Intellectual Property Organisation (WIPO) 06 Dec 2012
MAGEA3 BINDING ANTIBODIES Application WO-2012163769-A1 World Intellectual Property Organisation (WIPO) 06 Dec 2012
Antigenic polypeptide usable as therapeutic agent for malignant neoplasm Application US-8323657-B2 United States of America 04 Dec 2012
Process for the production of immunogenic compositions Grant US-8044183-B2 United States of America 25 Oct 2011
Antigenic polypeptide usable as therapeutic agent for malignant neoplasm Application EP-2322543-A1 European Patent Office 18 May 2011
Prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic… Grant US-7611892-B2 United States of America 03 Nov 2009
Real-time RT-PCR for the sensitive detection of multiple MAGE gene transcripts Grant US-7491814-B2 United States of America 17 Feb 2009
Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic… Grant US-7488809-B2 United States of America 10 Feb 2009
Secreted epithelial colon stromal-1 molecules and uses thereof Grant US-7329729-B1 United States of America 12 Feb 2008
MAGE-A4 antigenic peptides and uses thereof Application US-7311914-B2 United States of America 25 Dec 2007
Isolated nucleic acid molecules coding for tumor rejection antigen precursor MAGE-4 and… Grant US-7199231-B1 United States of America 03 Apr 2007
Human paris-1 antigen and nucleic acids: diagnostic and therapeutic uses Grant US-7087715-B2 United States of America 08 Aug 2006
Detection of breast metastases with a multiple marker assay Application EP-1505159-A1 European Patent Office 09 Feb 2005
MAGE-A3 PEPTIDES PRESENTED BY HLA CLASS II MOLECULES Application EP-1412748-A4 European Patent Office 12 Jan 2005
MAGE-A3 PEPTIDES PRESENTED BY HLA CLASS II MOLECULES Application EP-1412748-A2 European Patent Office 28 Apr 2004
Wnt-7B-like polypeptides and nucleic acids encoding same Grant US-6653448-B1 United States of America 25 Nov 2003
Structurally modified peptides that are resistant to peptidase degradation Grant US-6623740-B1 United States of America 23 Sep 2003
Chimeric polypeptide comprising the fragment B of shiga toxin and peptides of therapeutic… Grant US-6613882-B1 United States of America 02 Sep 2003
Methods for diagnosing multiple myeloma by determining rejection antigen precursors Grant US-6387630-B1 United States of America 14 May 2002
MAGE-10 encoding CDNA, the tumor rejection antigen precursor MAGE-10, antibodies specific… Grant US-6387698-B1 United States of America 14 May 2002
T-CELL EPITOPE OF MAGE-12 AND RELATED NUCLEIC ACIDS, VECTORS, CELLS, COMPOSITIONS AND… Application WO-2001074847-A3 World Intellectual Property Organisation (WIPO) 21 Mar 2002
MAGE-A12 ANTIGENIC PEPTIDES AND USES THEREOF Application WO-2001029220-A3 World Intellectual Property Organisation (WIPO) 07 Mar 2002
T-CELL EPITOPE OF MAGE-12 AND RELATED NUCLEIC ACIDS, VECTORS, CELLS, COMPOSITIONS AND… Application WO-2001074847-A2 World Intellectual Property Organisation (WIPO) 11 Oct 2001
Cell death inhibition by the caspase-12 activation inhibitor MAGE-3 Application EP-1126027-A1 European Patent Office 22 Aug 2001
ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-B FAMILY AND USES THEREOF Application EP-0910669-A4 European Patent Office 04 Apr 2001
ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF Application EP-0815118-A4 European Patent Office 04 Apr 2001
Structurally modified peptides that are resistant to peptidase degradation Grant US-6087441-A United States of America 11 Jul 2000
Polynucleotides encoding a human mage protein homolog Grant US-5912143-A United States of America 15 Jun 1999
Mage-10 encoding cDNA, the tumor rejection antigen precursor mage-10, antibodies specific… Grant US-5908778-A United States of America 01 Jun 1999
ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-B FAMILY AND USES THEREOF Application EP-0910669-A1 European Patent Office 28 Apr 1999
DETERMINATION OF CANCEROUS CONDITIONS BY MAGE GENE EXPRESSION Application EP-0871765-A1 European Patent Office 21 Oct 1998
REPLICATION-DEFECTIVE ADENOVIRUSES FOR CANCER IMMUNOTHERAPY Application WO-1998015638-A3 World Intellectual Property Organisation (WIPO) 02 Jul 1998
REPLICATION-DEFECTIVE ADENOVIRUSES FOR CANCER IMMUNOTHERAPY Application WO-1998015638-A2 World Intellectual Property Organisation (WIPO) 16 Apr 1998
MAGE-10 ENCODING cDNA, THE TUMOR REJECTION ANTIGEN PRECURSOR MAGE-10, ANTIBODIES SPECIFIC… Application WO-1998014463-A1 World Intellectual Property Organisation (WIPO) 09 Apr 1998
ISOLATED PEPTIDES WHICH COMPLEX WITH HLA-Cw*16 MOLECULES, AND USES THEREOF Application WO-1998010780-A1 World Intellectual Property Organisation (WIPO) 19 Mar 1998
ISOLATED NUCLEIC ACID MOLECULES WHICH ARE MEMBERS OF THE MAGE-Xp FAMILY AND USES THEREOF Application EP-0815118-A1 European Patent Office 07 Jan 1998
BABOON MAGE-3 HOMOLOGS, DNA ENCODING THE HOMOLOGS, AND A PROCESS FOR THEIR USE Application WO-1997013858-A3 World Intellectual Property Organisation (WIPO) 05 Jun 1997
BABOON MAGE-3 HOMOLOGS, DNA ENCODING THE HOMOLOGS, AND A PROCESS FOR THEIR USE Application WO-1997013858-A2 World Intellectual Property Organisation (WIPO) 17 Apr 1997